Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors

NCT00027677 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

NETWORK

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: halofuginone hydrobromide

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC